ForbesIBM's Watson Enters Market For Analyzing Cancer GeneticsForbesDr. Lukas Wartman is ground zero in the genetic battle against cancer. The assistant director of cancer genomics at Washington University in St. Louis developed acute lymphoblastic leukemia himself. When treatment options ran out, his colleagues looked to ...Health Buzz: IBM's Watson Will Identify Mutations and Targeted Cancer TherapiesU.S. News & World ReportIBM's Watson to guide cancer therapies at 14 centersReutersall 53 news articles »
IBM's Watson Enters Market For Analyzing Cancer Genetics
Rating: 4.5
Diposkan Oleh: Unknown
